The GLP-1 agonist Wegovy has re-energized the hunt for obesity treatments. Alternatives — ranging from bitter taste compounds to lean muscle boosters and bacteria — are already in the clinic.
© 2024 Aardvark Therapeutics, Inc. All Rights Reserved.